Spots Global Cancer Trial Database for fmiso
Every month we try and update this database with for fmiso cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study | NCT04995185 | Nasopharyngeal ... | (18)F-fluoromis... | 21 Years - 99 Years | National Cancer Centre, Singapore | |
| Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging | NCT03303469 | Hepatocellular ... | FMISO FMISO FMISO | 18 Years - | University of Alabama at Birmingham | |
| FMISO-based Adaptive Radiotherapy for Head and Neck Cancer | NCT05348486 | Head and Neck C... Hypoxia FMISO Dose Escalation | Dose escalation | 18 Years - | University Hospital Olomouc | |
| Clinical Evaluation of the New Hypoxia Imaging Agent HX4 | NCT01213030 | Head and Neck C... Lung Cancer Liver Cancer | [F-18] FMISO [F-18] HX4 | 18 Years - | Siemens Molecular Imaging | |
| Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment | NCT03547388 | Head and Neck N... Recurrence Tumo... | Moderate whole ... | 18 Years - 75 Years | Charite University, Berlin, Germany | |
| Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer | NCT01576796 | Stage III Non-s... | Radiotherapy | 18 Years - 99 Years | Centre Henri Becquerel | |
| Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging | NCT03303469 | Hepatocellular ... | FMISO FMISO FMISO | 18 Years - | University of Alabama at Birmingham | |
| MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00902577 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | FMISO MRI PET MRS | 18 Years - | National Cancer Institute (NCI) | |
| FMISO-based Adaptive Radiotherapy for Head and Neck Cancer | NCT05348486 | Head and Neck C... Hypoxia FMISO Dose Escalation | Dose escalation | 18 Years - | University Hospital Olomouc | |
| Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT | NCT01261585 | Bronchial Neopl... Carcinoma, Non-... | 18 Years - 75 Years | Centre Henri Becquerel | ||
| Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer | NCT01576796 | Stage III Non-s... | Radiotherapy | 18 Years - 99 Years | Centre Henri Becquerel | |
| Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging | NCT03303469 | Hepatocellular ... | FMISO FMISO FMISO | 18 Years - | University of Alabama at Birmingham |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
